Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 3Vaginal Neoplasms 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neuroendocrine Tumors 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Accelerated Phase 1Gallbladder Neoplasms 1Blast Crisis 1

Interventions

Gemcitabine 19Cisplatin 11Capecitabine 9Oxaliplatin 7Fluorouracil 5pembrolizumab 4Leucovorin 4Sorafenib 3Magnetic Resonance Spectroscopy 3Erlotinib Hydrochloride 3trifluridine tipiracil drug combination 2regorafenib 2cobimetinib 2atezolizumab 2Trastuzumab 2Taxes 2Specimen Handling 2Platinum 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Lapatinib 2Biopsy 2Bevacizumab 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2zanidatamab 1varlilumab 1vandetanib 1tucatinib 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Gallbladder Neoplasms × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all
NCT00075504 2015-09-28

Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer

National Cancer Institute (NCI)

Phase 2 Completed
33 enrolled 9 charts
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡